DSM-Firmenich AG (MEX:DSFIR N) ROC %: -1.12% (As of Dec. 2025)


MEX:DSFIR N DSM-Firmenich AG MEX:DSFIR N
51 GF Score
Price MXN1,301.79
GF Value MXN1,302.81
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG ROC %?

DSM-Firmenich AG MEX:DSFIR N 51 ROC % is -1.12% as of Dec. 2025. GuruFocus rates MEX:DSFIR N with a GF Score™ of 51/100 and a GF Value™ of MXN1,302.81. The stock has 5 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. DSM-Firmenich AG's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was -1.12%.

As of today (2026-06-24), DSM-Firmenich AG's WACC % is 3.18%. DSM-Firmenich AG's ROC % is 1.85% (calculated using TTM income statement data). DSM-Firmenich AG earns returns that do not match up to its cost of capital. It will destroy value as it grows.


DSM-Firmenich AG  (MEX:DSFIR N) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, DSM-Firmenich AG's WACC % is 3.18%. DSM-Firmenich AG's ROC % is 1.85% (calculated using TTM income statement data). DSM-Firmenich AG earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


DSM-Firmenich AG ROC % Related Terms


DSM-Firmenich AG ROC % Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG ROC % Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
ROC %
0.00 -1.69 1.76 1.82

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROC % Get a 7-Day Free Trial -0.92 0.52 2.83 4.68 -1.12
MEX:DSFIR N
51GF Score
DSM-Firmenich AG MEX:DSFIR N
ROC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG ROC % Calculation

DSM-Firmenich AG's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=13325.061 * ( 1 - 20.77% )/( (620386.1 + 538800.543)/ 2 )
=10557.4458303/579593.3215
=1.82 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=736981.474 - 57260.362 - ( 59335.012 - max(0, 95215.552 - 192156.34+59335.012))
=620386.1

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=618708.743 - 39785.428 - ( 40122.772 - max(0, 117922.576 - 187499.637+40122.772))
=538800.543

DSM-Firmenich AG's annualized Return on Capital (ROC %) for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-6493.86 * ( 1 - 2.78% )/( (587722.964 + 538800.543)/ 2 )
=-6313.330692/563261.7535
=-1.12 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=701914.353 - 52078.918 - ( 62112.471 - max(0, 74230.918 - 200019.529+62112.471))
=587722.964

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=618708.743 - 39785.428 - ( 40122.772 - max(0, 117922.576 - 187499.637+40122.772))
=538800.543

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROC % →
What does a ROC % of -1.12% mean?
DSM-Firmenich AG (MEX:DSFIR N) has a ROC % of -1.12% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on DSM-Firmenich AG and its competitors.
Is DSM-Firmenich AG's ROC % too high?
DSM-Firmenich AG's current ROC % is -1.12%. Overall, DSM-Firmenich AG has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's ROC % compare to LIN and SHW?
DSM-Firmenich AG's ROC % of -1.12% can be compared against companies in the Chemicals industry. The industry median ROC % is 4.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Chemicals company?
The median ROC % among Chemicals companies is 4.46, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median ROC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current ROC % is -1.12%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
DSM-Firmenich AG (MEX:DSFIR N) has a current ROC % of -1.12%. The stock's GF Value™ is MXN1,302.81, compared to a current price of MXN1,301.79 — trading 0.1% below its estimated fair value. The current ROC % is -1.12%. DSM-Firmenich AG's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For DSM-Firmenich AG (MEX:DSFIR N), the current ROC % is -1.12% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (MEX:DSFIR N) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be undervalued. The current stock price of MXN1,301.79 is trading 0.1% below its estimated GF Value™ of MXN1,302.81.

Key valuation signals for MEX:DSFIR N:

  • ROC %: -1.12%
  • GF Value™: MXN1,302.81 vs. price of MXN1,301.79 (0.1% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the MEX:DSFIR N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
51GF Score

Get the complete analysis for MEX:DSFIR N

ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,301.79
Price
MXN1,302.81
GF Value